May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Patrick Hwu highlights 2025 study by Jonathan Zager on Melphalan hepatic perfusion for metastatic uveal melanoma
May 10, 2025, 16:12

Patrick Hwu highlights 2025 study by Jonathan Zager on Melphalan hepatic perfusion for metastatic uveal melanoma

Patrick Hwu, President and CEO of Moffitt Cancer Center, shared an article by Jonathan S. Zager et al. on X, adding:

“Exciting multi-institutional study led Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with metastatic uveal melanoma.
Congrats to Jonathan Zager and colleagues!”

Read more about the study on the Moffitt Cancer Center website.

Title: An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma

Journal: Annals of Surgical Oncology

Authors: Jonathan S. Zager, Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J. Eschelman, Evan S. Glazer, Aslam Ejaz, J. Harrison Howard, Erika Richtig, Sebastian Ochsenreither, Sunil A. Reddy, Michael C. Lowe, Georgia M. Beasley, Anja Gesierich, Armin Bender, Martin Gschnell, Reinhard Dummer, Michel Rivoire, Ana Arance, Stephen William Fenwick, Joseph J. Sacco, Sebastian Haferkamp, Carsten Weishaupt, Johnny John, Matthew Wheater, Christian H. Ottensmeier

Read the full article.

Melphalan

More posts featuring  uveal melanoma on OncoDaily.